Additional studies are needed to assess the contributions of hyperinsulinemia and other obesogenic factors to upregulation of adipose Mettl3, Mettl14, and m6A‐based epitranscriptomic remodeling in obesity. The gene discussed is METTL3; the disease is hyperinsulinism.